Lacamas Laboratories Inc.
Portland, OR
- UEI
- L7D1LKAA9DY9
- CAGE
- 82ZN8
- Primary NAICS
- 325199 All Other Basic Organic Chemical Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325130 Synthetic Dye and Pigment Manufacturing
- 325194 Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing
- 325320 Pesticide and Other Agricultural Chemical Manufacturing
- 325412 Pharmaceutical Preparation Manufacturing
- 325910 Printing Ink Manufacturing
- 325920 Explosives Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- SAM.gov registration date
- Physical address
- 3625 N Suttle Rd, Portland, OR 97217, USA
- Website
- lacamaslabs.com
- Founded
- 1986
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,799,461 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cost reduction research, development and manufacturing for alternate nitramine precursors | Air Force Research Laboratory (AFMC) | $1,799,461 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| HII Mission Technologies Corp | FA807524F0022 | $400,469 | |
| HII Mission Technologies Corp | FA807524F0022 | $498,991 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Defense production act title III program, continuous technologies for ton-scale critical chemical production | Air Force | $106,995,857 |
Similar vendors
About the company
Lacamas Laboratories Inc., a small disadvantaged, veteran-owned manufacturer based in Portland, Oregon, conducts research, development, and manufacturing work for the Department of the Air Force and Department of Defense as a prime contractor on Small Business Innovation Research (SBIR) awards and as a subcontractor on munitions science and technology programs. The vendor operates predominantly as a prime (60% of recent awards) under small-business set-asides, with a footprint concentrated in chemical manufacturing and defense R&D.
Lacamas Laboratories' customer base is entirely within the Department of Defense. The Air Force Research Laboratory (AFRL) accounts for three awards with $1.8 million combined potential value, the Naval Sea Systems Command holds one award, and the Washington Headquarters Service (Defense Production Act Title III administration) holds one award. AFRL work dominates both award count and dollars. The vendor's primary capability involves cost reduction research, development, and manufacturing of alternate nitramine precursors and continuous technologies for ton-scale critical chemical production — work that sits at the intersection of organic chemistry and munitions-grade materials science.
The vendor's single active contract vehicle is the Information Analysis Center Multiple-Award Contract, with two task orders. Recent representative prime work includes a $1.8 million SBIR Phase II Firm Fixed Price contract awarded by AFRL in March 2025 for cost reduction research and manufacturing of alternate nitramine precursors, with performance through March 2027. Lacamas Laboratories also holds a Defense Production Act Title III Cooperative Agreement from the Washington Headquarters Service (awarded December 2023, completion December 2028) for continuous technologies supporting ton-scale critical chemical production. In its subcontractor role, the vendor delivers munitions science and technology R&D — both research materials and R&D chemicals — to HII Mission Technologies Corp on work supporting AFRL's Munitions Directorate (awards in June and July 2025). One award, the SBIR contract valued at $1.8 million, reaches completion inside the next twenty-four months and faces recompete exposure. Despite modest combined potential value ($1.8 million), the vendor has recognized $109.7 million in obligated dollars across all awards, indicating substantial progress payments or delivery performance on active grants.
SBA capabilities narrative
Lacamas Laboratories manufactures fine chemicals and pharmaceutical intermediates for the global market under cGMP guidelines. In addition, Safety and environmental compliance are paramount in all our operations. Our location in Portland, Oregon is a major hub for rail, air and sea transportation which facilitates reliable shipping to Asia and Europe.
We are experts in process development and scale-up and our goal is to develop scalable processes that are safe, robust and economic.
Our capabilities include:
Handling triphosgene - chloroformates, carbamates
Continuous processing - hazardous materials, organometallic chemistry
High temperature chemistry
Cryogenic reactions
DiBoc reagent (bulk) Boc protected intermediates
Distillation (ultra high vacuum and thin film)
Quick answers
Is Lacamas Laboratories Inc. registered in SAM.gov?
Yes. Lacamas Laboratories Inc.'s SAM.gov registration is active through May 19, 2027.
How much has Lacamas Laboratories Inc. received in federal contracts?
Federal contracts obligated $1,799,461 to Lacamas Laboratories Inc. in fiscal year 2025.
What is Lacamas Laboratories Inc.'s most recent federal award?
Lacamas Laboratories Inc.'s most recent federal contract award is Cost reduction research, development and manufacturing for alternate nitramine precursors (FA865125CB020), from Air Force Research Laboratory (AFMC), on March 10, 2025.
On GovTribe
See Lacamas Laboratories Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors